Simonian Nancy A
Transaction: 12/02/2024
SELL
Change
-37,070
Price
$0.27
Filing
12/04/2024
Type
SELL
Syros Pharmaceuticals, Inc.
SYRS • Biotechnology
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2024
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$15,734.309
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.95High debt level · 3.73Negative growth trendWeak profitability
Financial data as of: Sep 30, 2024, 12:00 AM UTCLast earnings update: Oct 31, 2024, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out39.34M
Market Cap$15.73K
Enterprise Value$-17.18M
52W Range0.00 - 0.02
Beta1.36
P/E-0.00
P/S0.04
P/B-0.00
P/FCF-0.00
EV/Sales-44.50
Price$0.00
Change0.00%
Shares Out39.34M
Market Cap$15.73K
Enterprise Value$-17.18M
52W Range0.00 - 0.02
Beta1.36
P/E-0.00
P/S0.04
P/B-0.00
P/FCF-0.00
EV/Sales-44.50
EV/EBITDA0.19
EV/FCF0.17
Dividend Yield0.00%
Gross Margin77.33%
Oper. Margin-12.98%
Profit Margin-16.56%
Debt/Eq3.73
Current Ratio3.95
Quick Ratio3.95
Target$16.67
Target Upside4167400.00%
Target Median$15.00
Target Range5.00 - 30.00
Volume904.00
Avg Volume11.35K
EPS Surprise-0.49
Investment DNA
How strong this company looks for long-term investors
27
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 3.95High debt level · 3.73Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
72/100
Bullish
Bullish
4
Hold
5
Bearish
0
Price Target
2026-09-02
Low
$5.00
Mean
$16.67
Median
$15.00
High
$30.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Simonian Nancy A
Transaction: 11/25/2024
SELL
Change
-134,713
Price
$0.27
Filing
11/27/2024
Type
SELL
Quirk Gerald E
Transaction: 11/19/2024
SELL
Change
-46,657
Price
$0.22
Filing
11/20/2024
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Simonian Nancy A | SELL | -37,070 | $0.27 | 12/02/2024 | 12/04/2024 |
| Simonian Nancy A | SELL | -134,713 | $0.27 | 11/25/2024 | 11/27/2024 |
| Quirk Gerald E | SELL | -46,657 | $0.22 | 11/19/2024 | 11/20/2024 |
| Haas Jason | SELL | -137,803 | $0.21 | 11/18/2024 | 11/20/2024 |
| Chee Conley | SELL | -134,797 | $0.20 | 11/18/2024 | 11/20/2024 |
| Roth David | SELL | -12,099 | $0.20 | 11/18/2024 | 11/20/2024 |
| Stephens Kristin | SELL | -36,133 | $0.22 | 11/18/2024 | 11/20/2024 |
| Stephens Kristin | SELL | -17,000 | Not reported | 10/31/2024 | 11/04/2024 |
| Stephens Kristin | SELL | -6,104 | $2.09 | 10/31/2024 | 11/04/2024 |
| Chee Conley | SELL | -17,000 | Not reported | 10/31/2024 | 11/04/2024 |
| Chee Conley | SELL | -8,707 | $2.09 | 10/31/2024 | 11/04/2024 |
| Haas Jason | SELL | -18,875 | Not reported | 10/31/2024 | 11/04/2024 |
| Haas Jason | SELL | -5,624 | $2.09 | 10/31/2024 | 11/04/2024 |
| Roth David | SELL | -18,875 | Not reported | 10/31/2024 | 11/04/2024 |
| Roth David | SELL | -6,776 | $2.09 | 10/31/2024 | 11/04/2024 |
| Simonian Nancy A | SELL | -40,125 | Not reported | 10/31/2024 | 11/04/2024 |
| Simonian Nancy A | BUY | +40,125 | Not reported | 10/31/2024 | 11/04/2024 |
| Quirk Gerald E | SELL | -10,000 | Not reported | 09/30/2024 | 10/02/2024 |
| Quirk Gerald E | SELL | -3,100 | $2.10 | 09/30/2024 | 10/02/2024 |
| Young Richard A | SELL | -2,667 | Not reported | 09/16/2024 | 09/18/2024 |